Comorbidities:
Fifteen (13%) patients diagnosed with asthma/wheezing were previously
followed-up. Of 113 patients, 2 were followed-up for prematurity, 1 for
congenital hypothyroidism, and 1 for gastroesophageal reflux disease
(GERD). During hospitalization, three (2.7%) patients were diagnosed
with selective IgA deficiency (n=1, CCAP and n=2, CAP), and one (0.9%)
of three children presented with transient hypogammaglobulinemia. One
patient presented with ASD on echocardiogram (ECHO) and one with PDA
based on the presence of heart murmur. Hence, comorbidities are not
significant risk factors for the development of CCAP (p=0.243)
(Table-1).
Due to secondary pulmonary hypertension (PHT) on ECHO, inhaled iloprost
was administered to one patient who received IMV in the PICU due to CCAP
and who was followed-up. With appropriate antibiotic therapy and
respiratory support, PHT improved; thus, treatment with inhaled iloprost
was discontinued. Two patients were diagnosed with GERD during
hospitalization based on clinical and radiological findings, and their
complaints improved with appropriate treatment during follow-up. One
patient with FBA who was followed-up for CCAP and whose anamnesis was
suspicious underwent rigid bronchoscopy, and YC was removed. One patient
with GT implantation who received TPA due to PPE and NO developed
pneumatocele. However, the condition improved with appropriate
antibiotic therapy during follow-up. One patient who received treatment
for LA presented with BPF, and surgery was performed because the patient
was symptomatic. Nevertheless, none of the patients underwent lobectomy.